Regeneron News, Regeneron Quote, REGN Quote

Regeneron (NQ:REGN) Delayed: 896.82 +2.83 (0.32%)

Prev. Close

$893.99

Open

$913.97

52 Wk High

$592.36

52 Wk Low

$325.35

Day High

$920.73

Day Low

$891.46

P/E

235.39

EPS

$3.81

Volume

507,468

Friends, Peers and Foes (?): MRNA, ALNY, AAPL, NVDA, AMZN (more...)

Apr 17, 2024 09:00 PM REGENERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Regeneron Pharmaceuticals, Inc. on Behalf of Regeneron Stockholders and Encourages Investors to Contact the Firm
Apr 17, 2024 08:14 AM Regeneron Pharma (REGN) PT Raised to $1,099 at UBS
Apr 12, 2024 09:21 AM Regeneron Pharma (REGN) PT Raised to $720 at BofA Securities
Apr 12, 2024 08:13 AM Regeneron Pharma (REGN) PT Raised to $1,060 at Jefferies
Apr 11, 2024 11:40 AM RBC on Regeneron Pharma (REGN):'The Buying Opportunity Many Have Been Looking For, With Overdone DOJ Downside On Top Of Recent Weakness'
Apr 11, 2024 08:12 AM Nike, Alpine Immune Sciences rise premarket; CarMax, Robinhood and Regeneron fall
Apr 10, 2024 04:59 PM US accuses Regeneron of fraudulent price reporting for eye drug
Apr 9, 2024 09:41 AM Regeneron Pharma (REGN) PT Raised to $1,177 at Morgan Stanley
Apr 7, 2024 04:00 PM Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma
Apr 3, 2024 04:06 PM Form 4 REGENERON PHARMACEUTICAL For: Apr 01 Filed by: RYAN ARTHUR F

Entities mentioned with regn